BioSpace News Archive

Drug Development

Spark Biomedical Awarded $1.15M Department of Defense Phase II STTR Grant in Partnership with Battelle Memorial Institute

Spark Biomedical, Inc. was awarded a $1.15M Phase II grant to develop a Transcutaneous Auricular Neurostimulation device, Sparrow® Hawk, to address the adverse effects of acute stress reaction.

August 29, 2023
·
5 min read
Policy

FDA Roundup: August 29, 2023

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

August 29, 2023
·
1 min read
Biotech Bay

Iridex Announces Strategic Review to Unlock Shareholder Value

Iridex Corporation announced that its Board of Directors is undertaking, in consultation with its financial and legal advisors, a review and evaluation of strategic alternatives that may be available to the Company to unlock shareholder value.

August 29, 2023
·
3 min read
Biotech Bay

Personalis to Present at the 21st Annual Morgan Stanley Global Healthcare Conference

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will present at the 21st Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 12, 2023 at 4:55 p.m. Eastern Time in New York, NY at the Sheraton New York.

August 29, 2023
·
1 min read
BioMidwest

Baxter to Present at Morgan Stanley 21st Annual Global Healthcare Conference

Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Morgan Stanley 21st Annual Global Healthcare Conference on Wednesday, September 13, 2023.

August 29, 2023
·
1 min read
Biotech Bay

Vir Biotechnology to Participate in Upcoming September 2023 Investor Healthcare Conferences

Vir Biotechnology, Inc. announced that management will be participating in the following upcoming investor conferences during the month of September.

August 29, 2023
·
1 min read
Biotech Bay

10x Genomics Surpasses 100 Xenium Analyzer Shipments

10x Genomics, Inc., a leader in single cell and spatial biology, announced that it has shipped more than 100 Xenium Analyzer instruments in the eight months since the platform’s launch.

August 29, 2023
·
10 min read
Policy

AHF Commends Biden for Drug Price Controls

AIDS Healthcare Foundation commended President Joseph Biden on his administration’s efforts to control drug pricing by compelling pharmaceutical companies choosing to participate in Medicare to engage in drug price negotiations.

August 29, 2023
·
1 min read
Telo Genomics Reports Substantial Progress Toward Clinical Launch of TeloView-SMM

Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the “Company” or “Telo”) is pleased to provide an update on the planned launch of the TeloView®SMM (Smoldering Multiple Myeloma) assay in the fourth quarter of this year.

August 29, 2023
·
3 min read
Epigenic Therapeutics Announces $32 Million in Series A Funding to Bring Breakthrough Epigenome Medicine to Clinical Development

Epigenic Therapeutics today announced that it has raised $32 million in Series A round of financing co-led by Qiming Venture Partners and OrbiMed, with participation from existing investor Morningside Venture Capital.

August 29, 2023
·
5 min read